These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2954724)

  • 1. Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty.
    Barnathan ES; Schwartz JS; Taylor L; Laskey WK; Kleaveland JP; Kussmaul WG; Hirshfeld JW
    Circulation; 1987 Jul; 76(1):125-34. PubMed ID: 2954724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intracoronary dipyridamole reduces the incidence of acute coronary vessel occlusion in percutaneous transluminal coronary angioplasty--a prospective randomized study].
    Heintzen MP; Heidland UE; Klimek WJ; Michel CJ; Kelm M; Leschke M; Schwartzkopff B; Vester EG; Strauer BE
    Z Kardiol; 1997 Dec; 86(12):961-7. PubMed ID: 9499493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.
    Schwartz L; Bourassa MG; Lespérance J; Aldridge HE; Kazim F; Salvatori VA; Henderson M; Bonan R; David PR
    N Engl J Med; 1988 Jun; 318(26):1714-9. PubMed ID: 2967433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management and immediate outcome of patients with intracoronary thrombus during percutaneous transluminal coronary angioplasty.
    Vaitkus PT; Herrmann HC; Laskey WK
    Am Heart J; 1992 Jul; 124(1):1-8. PubMed ID: 1615790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pretreatment with aspirin versus aspirin plus dipyridamole on frequency and type of acute complications of percutaneous transluminal coronary angioplasty.
    Lembo NJ; Black AJ; Roubin GS; Wilentz JR; Mufson LH; Douglas JS; King SB
    Am J Cardiol; 1990 Feb; 65(7):422-6. PubMed ID: 2407084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracoronary dipyridamole reduces the incidence of abrupt vessel closure following PTCA: a prospective randomised trial.
    Heintzen MP; Heidland UE; Klimek WJ; Leschke M; Kelm M; Schwartzkopff B; Vester EG; Michel CJ; Strauer BE
    Heart; 2000 May; 83(5):551-6. PubMed ID: 10768906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ticlopidine in the prevention of thrombus formation after percutaneous transluminal coronary angioplasty (PTCA).
    Chotinaiwattarakul C; Mahanonda N; Kangkagate C; Chaithiraphan S
    J Med Assoc Thai; 1997 Feb; 80(2):76-80. PubMed ID: 9078690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the methodology of percutaneous transluminal coronary angioplasty on restenosis.
    Douglas JS; King SB; Roubin GS
    Am J Cardiol; 1987 Jul; 60(3):29B-33B. PubMed ID: 2956837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, in preventing restenosis after percutaneous transluminal coronary angioplasty.
    Okamoto S; Inden M; Setsuda M; Konishi T; Nakano T
    Am Heart J; 1992 Jun; 123(6):1439-44. PubMed ID: 1595521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergent use of balloon-expandable coronary artery stenting for failed percutaneous transluminal coronary angioplasty.
    Herrmann HC; Buchbinder M; Clemen MW; Fischman D; Goldberg S; Leon MB; Schatz RA; Tierstein P; Walker CM; Hirshfeld JW
    Circulation; 1992 Sep; 86(3):812-9. PubMed ID: 1516193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunctive intracoronary dipyridamole in the interventional treatment of small coronary arteries: a prospectively randomized trial.
    Heidland UE; Heintzen MP; Michel CJ; Strauer BE
    Am Heart J; 2000 Jun; 139(6):1039-45. PubMed ID: 10827385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracoronary urokinase for intracoronary thrombus accumulation complicating percutaneous transluminal coronary angioplasty in acute ischemic syndromes.
    Schieman G; Cohen BM; Kozina J; Erickson JS; Podolin RA; Peterson KL; Ross J; Buchbinder M
    Circulation; 1990 Dec; 82(6):2052-60. PubMed ID: 2242529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Incidence, predisposing factors, acute complications and prognostic significance of intracoronary thrombus formation during PTCA].
    Schächinger V; Kasper W; Wollschläger H; Zeiher AM
    Z Kardiol; 1993 Nov; 82(11):712-20. PubMed ID: 8291293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect on early acute occlusion rate of adjunctive antithrombotic treatment with intravenously administered dipyridamole during percutaneous transluminal coronary angioplasty.
    Danchin N; Juillière Y; Kettani C; Buffet P; Anconina J; Cuillière M; Cherrier F
    Am Heart J; 1994 Mar; 127(3):494-8. PubMed ID: 8122594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of intracoronary thrombus in acute complications during percutaneous transluminal coronary angioplasty.
    Arora RR; Platko WP; Bhadwar K; Simpfendorfer C
    Cathet Cardiovasc Diagn; 1989 Apr; 16(4):226-9. PubMed ID: 2523243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of intracoronary thrombosis complicating percutaneous transluminal coronary angioplasty.
    Boston DR; Malouf A; Barry WH
    Clin Cardiol; 1996 Jul; 19(7):536-42. PubMed ID: 8818433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty.
    Corcos T; David PR; Val PG; Renkin J; Dangoisse V; Rapold HG; Bourassa MG
    Am Heart J; 1985 May; 109(5 Pt 1):926-31. PubMed ID: 3158187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty by intracoronary application of dipyridamole: impact on hemodynamic function and left ventricular performance.
    Strauer BE; Heidland UE; Heintzen MP; Schwartzkopff B
    J Am Coll Cardiol; 1996 Nov; 28(5):1119-26. PubMed ID: 8890804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty (PTCA) by intracoronary dipyridamole: hemodynamic, contractile and dynamic ventricular consequences].
    Strauer BE; Heidland UE; Heintzen MP; Schwartzkopff B
    Z Kardiol; 1995 Nov; 84(11):898-910. PubMed ID: 8571641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New aspects of blood coagulation inhibitory therapy within the scope of percutaneous transluminal coronary angioplasty (PTCA)].
    Schächinger V; Zeiher AM
    Z Kardiol; 1995 Sep; 84(9):651-67. PubMed ID: 8525667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.